These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2465404)

  • 1. Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release.
    Robinson WE; Montefiori DC; Gillespie DH; Mitchell WM
    J Acquir Immune Defic Syndr (1988); 1989; 2(1):33-42. PubMed ID: 2465404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors.
    Robinson WE; Montefiori DC; Mitchell WM
    Virology; 1990 Apr; 175(2):600-4. PubMed ID: 2327077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing antibodies in HIV infection.
    Füst G
    Parasitology; 1997; 115 Suppl():S127-40. PubMed ID: 9571698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line.
    Gras GS; Dormont D
    J Virol; 1991 Jan; 65(1):541-5. PubMed ID: 1845908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.
    Boyer V; Desgranges C; Trabaud MA; Fischer E; Kazatchkine MD
    J Exp Med; 1991 May; 173(5):1151-8. PubMed ID: 1827139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load.
    Szabó J; Prohászka Z; Tóth FD; Gyuris A; Segesdi J; Bánhegyi D; Ujhelyi E; Minárovits J; Füst G
    AIDS; 1999 Oct; 13(14):1841-9. PubMed ID: 10513641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and virus-specific antibody-dependent infection of normal B lymphocytes by human immunodeficiency virus type 1.
    Gras G; Richard Y; Roques P; Olivier R; Dormont D
    Blood; 1993 Apr; 81(7):1808-18. PubMed ID: 8461467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro.
    Tóth FD; Mosborg-Petersen P; Kiss J; Aboagye-Mathiesen G; Zdravkovic M; Hager H; Aranyosi J; Lampé L; Ebbesen P
    Clin Exp Immunol; 1994 Jun; 96(3):389-94. PubMed ID: 8004808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells.
    Tremblay M; Meloche S; Sekaly RP; Wainberg MA
    J Exp Med; 1990 May; 171(5):1791-6. PubMed ID: 2159052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection.
    Lund O; Hansen J; Søorensen AM; Mosekilde E; Nielsen JO; Hansen JE
    J Virol; 1995 Apr; 69(4):2393-400. PubMed ID: 7884885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for complement-mediated, antibody-dependent enhancement of human immunodeficiency virus type 1 infection in MT2 cells is enhanced entry through CD4, CD21, and CXCR4 chemokine receptors.
    Robinson WE
    Viral Immunol; 2006; 19(3):434-47. PubMed ID: 16987062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation.
    June RA; Schade SZ; Bankowski MJ; Kuhns M; McNamara A; Lint TF; Landay AL; Spear GT
    AIDS; 1991 Mar; 5(3):269-74. PubMed ID: 1829367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection.
    Prohászka Z; Nemes J; Hidvégi T; Tóth FD; Kerekes K; Erdei A; Szabó J; Ujhelyi E; Thielens N; Dierich MP; Späth P; Ghebrehiwet B; Hampl H; Kiss J; Arlaud G; Füst G
    AIDS; 1997 Jul; 11(8):949-58. PubMed ID: 9223728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection.
    Tóth FD; Szabó B; Ujhelyi E; Pálóczi K; Horváth A; Füst G; Kiss J; Bánhegyi D; Hollán SR
    AIDS; 1991 Mar; 5(3):263-8. PubMed ID: 1676275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages.
    Shadduck PP; Weinberg JB; Haney AF; Bartlett JA; Langlois AJ; Bolognesi DP; Matthews TJ
    J Virol; 1991 Aug; 65(8):4309-16. PubMed ID: 1712861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies.
    Tremblay M; Numazaki K; Li XG; Gornitsky M; Hiscott J; Wainberg MA
    J Immunol; 1990 Nov; 145(9):2896-901. PubMed ID: 1698866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis.
    Saifuddin M; Ghassemi M; Patki C; Parker CJ; Spear GT
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):829-37. PubMed ID: 7527236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro.
    Matsuda S; Gidlund M; Chiodi F; Cafaro A; Nygren A; Morein B; Nilsson K; Fenyö EM; Wigzell H
    Scand J Immunol; 1989 Oct; 30(4):425-34. PubMed ID: 2554488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody.
    Montefiori DC; Zhou J; Shaff DI
    Clin Exp Immunol; 1992 Dec; 90(3):383-9. PubMed ID: 1360879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-dependent virolysis of HIV-1 with monoclonal antibody NM-01.
    Nakamura M; Sasaki H; Terada M; Ohno T
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):619-26. PubMed ID: 8369167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.